Manitex Capital Inc. announced that it has appointed Dr. Ed Margerrison as President and CEO. Dr. Margerrison is an industry veteran with 25 years experience in the orthopedic industry. A Ph.D in molecular biology, Dr. Margerrison most recently led the biologics division of Zimmer Inc. Prior to this, Dr. Margerrison had spent 14 years at Smith & Nephew Orthopedics.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.31 CAD | +24.00% | +24.00% | +34.78% |
03-29 | Manitex Capital Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
02-28 | Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+34.78% | 2.85M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
+11.88% | 216B | |
-0.78% | 219B | |
+5.90% | 164B |
- Stock Market
- Equities
- MNX Stock
- News Manitex Capital Inc.
- Manitex Capital Inc. Appoints Ed Margerrison as President and CEO